Multiple Sclerosis

Benefits of the contract

The LPP monitors the use of multiple sclerosis medicines, where there are price changes, or at the end of the patent, when generic versions become available. The volumes are taken from IQVIA and Define databases. The contract is owned by the Commercial Medicines Unit.

Contract description

Applicable to all London trusts providing services for multiple sclerosis. 

Contract Overview
Start 01-04-18
End 31-03-20
Contract Type Contract
Accessible to London Only LPP Members
Authority NHS Commercial Medicines Unit
OJEU Award Ref
Initial Period (Years) 1.00
Extensions remaining 0.00
LPP Contact Jackie Eastwood
07500 573068
LPP Ref Multiple Sclerosis